Rationally designed BCR-ABL kinase inhibitors for improved leukemia treatment via covalent and pro-/dual-drug targeting strategies

Autor: Sun, Jie, Lou, Liang, Zhu, Chengjun, Chen, Peng, Tang, Guanghui, Gu, Mingxi, Xia, Shu, Dong, Xiao, Zhang, Zhi-Min, Gao, Liqian, Yao, Shao Q., Xiao, Qicai
Zdroj: In Journal of Advanced Research September 2024
Databáze: ScienceDirect